http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112020008756-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3be73a6503a35f7233b0ca080ad2d08e
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5036
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513
filingDate 2018-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a71a08d7298f687c50d7b0231cfc28c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50aaf04879998c464a13cd8713cd948b
publicationDate 2020-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-112020008756-A2
titleOfInvention oral pharmaceutical compositions of lorazepam resistant to alcohol
abstract oral pharmaceutical compositions and alcohol-resistant dosage forms that exhibit reduced drug release in the presence of alcohol are described herein. the compositions comprise a substrate comprising a controlled release formulation of lorazepam and an alcohol resistant coating surrounding the substrate.
priorityDate 2017-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452523935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453837589
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408839960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22814120
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451905405
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6850754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415775290
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82285
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62223
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6328154
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21872322
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57503849
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665634
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533788
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452742552
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452788844
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453754419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448546691

Total number of triples: 48.